Effects of Teratogenic Drugs on CYP1A1 Activity in Differentiating Rat Embryo Cells

Abstract

CYP1A1, a P450 isoenzyme, is involved in the phase I xenobiotic metabolism including teratogen drugs. In the present study, the ability of teratogens to elevate the embryonic expression of CYP1A1 was examined. Micromass cell cultures prepared from day 13 rat embryo limb buds (LB). LB cells were cultivated and exposed for 5 days to retinoic acid (RA), hydrocortisone (HC), caffeine (CA) and quinine (QN). CYP1A1 protein expression and activity were measured using immunofluorescence staining and ethoxyresorufin O-deethylation (EROD) assay, respectively. The EROD activity increased significantly following LB cells exposure to RA and HC (p<0.05) but the expression of CYP1A1 protein was reduced by these drugs, whereas the expression of CYP1A1 protein and EROD activity decreased significantly following the addition of CA and QN (p<0.05, p<0.01). Our findings show that studied teratogens have potency to increase CYP1A1 activity.

Key words

hydrocortisone - limb bud - micromass culture - retinoic acid

^* Correspondence to Prof. Seyed Nasser Ostad for teratogenicity micromass culture assay and immunofluorescence microscopy & to Prof. Omid Sabzevari for enzyme activity assay.

• References

• 1 Whitlock Jr JP. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 1999; 39: 103-125
• 2 Dragin N, Dalton TP, Miller ML et al. For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential. J Biol Chem 2006; 281: 18591-18600
• 3 Brown LP, Flint OP, Orton TC et al. In vitro metabolism of teratogens by differentiating rat embryo cells. Food Chem Toxicol 1986; 24: 737-742
• 4 Nebert DW, Gonzalez FJ. P450 genes: structure, evolution, and regulation. Annu Rev Biochem 1987; 56: 945-993
• 5 Nebert DW, Roe AL, Dieter MZ et al. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 2000; 59: 65-85
• 6 Gordon GB, Spielberg SP, Blake DA et al. Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite. Proc Natl Acad Sci 1981; 78: 2545-2548
• 7 Stephens TD, Bunde CJ, Fillmore BJ. Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol 2000; 59: 1489-1499
• 8 Jaruchotikamol A, Jarukamjorn K, Sirisangtrakul W et al. Strong synergistic induction of CYP1A1 expression by andrographolide plus typical CYP1A inducers in mouse hepatocytes. Toxicol Appl Pharmacol 2007; 224: 156-162
• 9 Brown LP, Foster JR, Orton TC et al. Localization and identification of cytochrome P-450 in differentiating rat embryo cells in vitro and in foetal tissue in vivo by immunocytochemistry. Toxicol In Vitro 1989; 3: 245-252
• 10 Brown LP, Foster JR, Orton TC et al. Inducibility and functionality of rat embryonic/foetal cytochrome P450: a study of differentiating limb bud and midbrain cells in vitro. Toxicol In Vitro 1989; 3: 253-260
• 11 Flint OP, Brown LP. Metabolism of teratogens by mammalian embryos: an in vitro investigation. In: Nau H, Scott WJ. (eds.). Pharmacokinetics in teratogenesis. Boca Raton: CRC Press; 1987: 133-144
• 12 Flint OP. An in vitro test for teratogens using cultures of rat embryo cells. In: Atterwill CK, Steele GE. (eds.). In vitro methods in toxicology. Cambridge: Cambridge University Press; 1987: 339-363
• 13 Schardein JL. Drugs as teratogens. Ohio: CRC Press; 1976: 113-122
• 14 Flint OP, Orton TC, Ferguson RA. Differentation of rat embryo cells in culture: Response following acute maternal exposure to teratogens and non-teratogens. J Appl Toxicol 1984; 4: 109-116
• 15 Ede DA, Flint OP, Wilby OK et al. The development of precartilage condensations in limb bud mesenchyme in vivo and in vitro. In: Ede DA, Hinchliffe JR, Balls M. (eds.). Vertebrate limb and somite morphogenesis. Cambridge: Cambridge University Press; 1977: 161-179
• 16 Flint OP. The effects of sodium salicylate, cytosine arabinoside, and eserine sulphate on rat limb buds in culture. In: Merker HJ, Nau H, Neubert D. (eds.). Teratology of the limbs. Berlin. NY: Walter de Gruyter Publ; 1980: 325-338
• 17 Grundmann K, Zimmermann B, Barrach HJ et al. Behaviour of epiphyseal mouse chondrocyte populations in monolayer culture. Virchows Arch 1980; 389: 167-187
• 18 Caplan AI, Syftestad G, Osdoby P. The development of embryonic bone and cartilage in tissue culture. Clin Orthop Relat Res 1983; 174: 243-263
• 19 Flint OP, Orton TC. An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells. Toxicol Appl Pharmacol 1984; 76: 383-395
• 20 Ostad SN, Khakinegad B, Sabzevari O. Evaluation of the teratogenicity of fennel essential oil (FEO) on the rat embryo limb buds culture. Toxicol In Vitro 2004; 18: 623-627
• 21 Kistler A, Howard WB. Testing of retinoids for teratogenicity in vitro: Use of micromass limb bud cell culture. Methods Enzymol 1990; 190: 427-433
• 22 Skupinska K, Misiewicz-Krzeminska I, Lubelska K et al. The effect of isothiocyanates on CYP1A1 and CYP1A2 activities induced by polycyclic aromatic hydrocarbons in Mcf7 cells. Toxicol In Vitro 2009; 23: 763-771
• 23 Kennedy SW, Lorenzen A, James CA et al. Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader. Anal Biochem 1993; 211: 102-112
• 24 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254
• 25 Ward SJ, Newall DR. The micromass test: Is it subject to strain variation?. Toxicol In Vitro 1990; 4: 620-622
• 26 Newall DR, Beedles KE. The stem-cell test-A novel in vitro assay for teratogenic potential. Toxicol In Vitro 1994; 8: 697-701
• 27 Parsons JF, Rockley J, Richold M. In vitro micromass teratogen test: Interpretation of results from a blind trial of 25 compounds using three separate criteria. Toxicol In Vitro 1990; 4: 609-611
• 28 Kosazuma T, Hashimoto S, Ohno H et al. Organ culture of the fetal mouse palate for screening the developmental toxicity of chemicals: A validation study. Congenit Anom 2004; 44: 60-71
• 29 Yu Z, Xing Y. All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-β/Smad signaling. Biochem Biophys Res Commun 2006; 340: 929-934
• 30 Kistler A, Mislin M, Gehrig A. Chondrogenesis of limb-bud cells: improved culture method and the effect of the potent teratogen retinoic acid. Xenobiotica 1985; 15: 673-679
• 31 Liu W, Levi G, Shanske A et al. Retinoic acid-induced inner ear teratogenesis caused by defective Fgf3/Fgf10-dependent Dlx5 signaling. Birth Defects Res B Dev Reprod Toxicol 2008; 83: 134-144
• 32 Hillegass JM, Villano CM, Cooper KR et al. Matrix metalloproteinase-13 is required for zebra fish (Danio rerio) development and is a target for glucocorticoids. Toxicol Sci 2007; 100: 168-179
• 33 Seichert V, Heringová L, Seichertová A et al. Development of the ectopia cordis induced by hydrocortisone administration. Folia Biol (Praha) 2000; 46: 49-56
• 34 West PR, Weir AM, Smith AM et al. Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics. Toxicol Appl Pharmacol 2010; 247: 18-27
• 35 Iwanari M, Nakajima M, Kizu R et al. Induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch Toxicol 2002; 76: 287-298
• 36 Khlood EB, Miyoshi H, Iwata H et al. Effects of concurrent exposure to 3-methylcholanthrene and vitamin A on fetal development in rats. Jpn J Vet Res 1999; 47: 13-23
• 37 Jurima-Romet M, Neigh S, Casley W. Induction of cytochrome P450 3A by retinoids in rat hepatocyte culture. Hum Exp Toxicol 1997; 16: 198-203
• 38 Vecchini F, Lenoirviale MC, Cathelineau C et al. Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem Biophys Res Commun 1994; 201: 1205-1212
• 39 Vecchini F, Mace K, Magdalou J et al. Constitutive and inducible expression of drug metabolizing enzymes in cultured human keratinocytes. Br J Dermatol 1995; 132: 14-21
• 40 Soprano DR, Gambone CJ, Sheikh SN et al. The synthetic retinoid AGN 193109 but not retinoic acid elevates CYP1A1 levels in mouse embryos and Hepa-1c1c7 cells. Toxicol Appl Pharmacol 2001; 174: 153-159
• 41 Villard PH, Barlesi F, Armand M et al. CYP1A1 induction in the colon by serum: involvement of the PPARα pathway and evidence for a new specific human PPREα site. PLoS One 2011; 6: e14629
• 42 Abbott BD, Perdew GH, Buckalew AR et al. Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol Appl Pharmacol 1994; 128: 138-150
• 43 Abbott BD, Schmid JE, Brown JG et al. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol Sci 1999; 47: 76-85
• 44 Sonneveld E, Jonas A, Meijer OC et al. Glucocorticoid-enhanced expression of dioxin target genes through regulation of the rat aryl hydrocarbon receptor. Toxicol Sci 2007; 99: 455-469
• 45 Dvořák Z, Vrzal R, Pávek P et al. An evidence for regulatory cross-talk between aryl hydrocarbon receptor and glucocorticoid receptor in HepG2 cells. Physiol Res 2008; 57: 427-435
• 46 Bielefeld KA, Lee C, Riddick DS. Regulation of aryl hydrocarbon receptor expression and function by glucocorticoids in mouse hepatoma cells. Drug Metab Dispos 2008; 36: 543-551
• 47 Eugster HP, Probst M, Würgler FE et al. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae . Drug Metab Dispos 1993; 21: 43-49
• 48 Ayalogu EO, Snelling J, Lewis DFV et al. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim Biophys Acta 1995; 1272: 89-94
• 49 Goasduff T, Dréano Y, Guillois B et al. Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem Pharmacol 1996; 52: 1915-1919
• 50 Ching MS, Blake CL, Malek NA et al. Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine. Xenobiotica 2001; 31: 757-767
• 51 Granvil CP, Krausz KW, Gelboin HV et al. 4-Hydroxylation of debrisoquine by human CYP1A1 and its inhibition by quinidine and quinine. J Pharmacol Exp Ther 2002; 301: 1025-1032